News

Requirement to "adapt" description to allowable claim and to potentially comprehensively rewrite the description may soon be history – but at least for Germany, voluntary amendments may be advantageous

EPO BoA T 56/21 (F. Hoffmann-La Roche AG) of October 4, 2024
 read

Remarks on an important decision on the competence of the UPC

In a significant decision on 12 November 2024, the Court of Appeal clarified the application of Article 83 UPCA, extending the Unified Patent Court's (UPC) competence to patents previously thought excluded; AIM Sport Development AG v. Supponor OY (UPC_CoA_489/2023).
 read

Yet another success for our team in JUVE Patent's Germany ranking 2024

Our firm has been rated three stars in the “Litigation” ranking. JUVE explicates WR as "well positioned for patent disputes because the patent attorneys and lawyers work closely together."  JUVE further states: "The large base of prosecution clients regularly turns to the firm for comprehensive…
 read

The “Bolar” Exemption in Europe

Dr Holger Tostmann elaborates the two mechanisms for exemption of medicinal products from patent protection which exist in Europe: the so-called "research exemption" and the "Bolar exemption". This article has been published in the fall newsletter of AIPLA's Chemical Practice Chronicles.
 read
Dr. Holger Tostmann

WR among Germany’s top 2% law firms recognized for excellence (Best Law Firms™- Germany)

We are happy to announce that our law firm has been recognized in Tier 1 for both intellectual property law and patent law.
 read
Search form